Topic: Avastin
According to the World Health Organisation the number of cancer deaths worldwide could double by 2030 to reach 13 million. Patients who are suffering from lethal types of cancers, like brain, lung, liver, ovarian and pancreas, do not respond well to existing ...
A panel of experts on Tuesday recommended that the US Food and Drug Administration (FDA) withdraw approval of Roche's best-selling cancer drug Avastin for the treatment of breast cancer. Experts on the advisory panel voted 12 to one to recommend that the ...
GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel dealt a blow to Roche Holding's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. regulators to revoke the medicine's approval for treating breast cancer. The committee voted 12-1 to recommend withdrawal of Avastin's breast ...
GAITHERSBURG, Maryland (Reuters) - A U.S. advisory panel dealt a blow to Roche Holding's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. regulators to revoke the medicine's approval for treating breast cancer. The committee voted 12-1 to recommend withdrawal of Avastin's breast ...
FDA panel: risks of Roche drug for breast cancer patients outweigh benefits in key studyFederal health advisers say unanimously that a follow-up study of the Roche drug Avastin failed to show meaningful benefits for breast cancer patients. A Food and Drug Administration ...
The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced form of one of the most common lung cancers, researchers report.. "Today we have a new option to treat non-squamous lung cancer, incorporating ...
FDA says follow-up studies of Avastin don't show benefit for breast cancer patientsFederal health scientists say follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential halt ...
WASHINGTON (Reuters) - A U.S. advisory panel will meet in July to review two proposed new uses for Roche Holding AG's blockbuster cancer drug Avastin, the Food and Drug Administration said on Thursday. The committee of outside experts at a July 20 ...
Novel drug combo boosts survival of breast cancer patients with advanced disease, study findsSome women with very advanced breast cancer may have a new treatment option. Its maker, Genentech, says the wholesale price it charges for the drug averages $7,700 a month.Considering ...
ZURICH (Reuters) - Roche Holding AG said on Wednesday three studies on its drugs used to treat early and advanced breast cancer showed good results.The Swiss drugmaker, the world's largest maker of cancer drugs, was due to present the results in coming ...
